Indexed with PubMed and Science Citation Index (E) 
Users online: 5685 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Article in PDF (2,269 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Case Report
   Article Figures

 Article Access Statistics
    PDF Downloaded126    
    Comments [Add]    

Recommend this journal


Year : 2010  |  Volume : 76  |  Issue : 3  |  Page : 273-275

Nodular amelanotic melanoma

Department of Dermatology, Seth G S Medical College and KEM Hospital, Parel, Mumbai, India

Date of Web Publication4-May-2010

Correspondence Address:
Uday Khopkar
Department of Dermatology, Seth GS Medical College and KEM Hospital, Parel, Mumbai-400 012
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0378-6323.62972

Rights and Permissions


We report a case of 65-year-old male patient who presented with multiple erythematous papules coalescing to form a nodular mass over posterior aspect of right thigh of six months duration. His general and systemic examinations were within normal range except for right inguinal lymphadenopathy. Biopsy from the lesion was done, which showed diffuse infiltrate of nests of atypical melanocytes extending upto reticular dermis. Malignant cells were positive for S100 and human melanin black 45(HMB 45). Hence, a diagnosis of amelanotic melanoma (AM) - Clarke level IV and TNM stage III was reached. MRI of involved leg showed fungating soft tissue mass in the posterolateral aspect of right thigh and metastatic right inguinal adenopathy. Fine needle aspiration cytology (FNAC) from the right inguinal nodes confirmed metastasis of melanoma. The patient was referred to oncosurgery department for further management.

Keywords: Amelanotic melanoma, HMB45, Immunohistochemistry, pigment melanin, pigmented rim or border, S100

How to cite this article:
Nalamwar R, Kharkar V, Mahajan S, Chikhalkar S, Khopkar U. Nodular amelanotic melanoma. Indian J Dermatol Venereol Leprol 2010;76:273-5

How to cite this URL:
Nalamwar R, Kharkar V, Mahajan S, Chikhalkar S, Khopkar U. Nodular amelanotic melanoma. Indian J Dermatol Venereol Leprol [serial online] 2010 [cited 2020 Aug 14];76:273-5. Available from:

  Introduction Top

The incidence of amelanotic melanomas (AMs) has been estimated between 1.8-8.1% of all melanomas. [1] It presents diagnostic difficulty for the clinicians, as it lacks the usual melanin pigment and no fixed criteria for diagnosis are available. The most common presentation of AMs is of nodular variety. Although AM frequently shows a few melanin granules it is often difficult to differentiate from nonepithelial malignant tumors. [2] Immunohistochemistry is an important tool in the diagnosis of AM. We report a case of AM of nodular variety.

  Case Report Top

A 65-year-old male patient presented with a painless progressive nodular mass over posterior aspect of right thigh of six months duration with ulceration, slough and secondary infection at places [Figure 1]. Initially, a few erythematous papules had appeared on posterior aspect of right thigh six months back and then several such lesions appeared and had coalesced to form a large tumor mass. There was no history of significant weight loss in the past six months nor was there history of breathlessness, upper quadrant discomfort, bony pain or any orificial bleeding. On cutaneous examination multiple, erythematous, clustered nontender papulonodules that had coalesced to form a plaque of approximate size 10Χ8 cm were present. The plaque showed surface ulceration, slough and peripheral blackish pigmentation. The involved extremity showed pitting edema and induration. Right inguinal lymph nodes were enlarged, firm, nontender and ranged in size from 2-3cm in diameter. We considered the differential diagnoses of squamous cell carcinoma, cutaneous metastasis from unknown primary, AM and lymphangiosarcoma.

His routine blood biochemistry and hemogram were within normal limits. The serology for hepatitis B surface antigen, hepatitis C and human immunodeficiency virus was negative. His blood sugars both fasting (94 mg/dl) and postprandial (111 mg/dl) were within normal limits. His chest roentgenogram and electrocardiogram were within normal limits. Histopathological examination from one of the lesions showed diffuse infiltration up to reticular dermis by nests of malignant melanocytes. The cytoplasm was abundant, granular with scanty melanin granules. Mitotic figures were frequent. Clarke level was IV and Breslow's thickness was 3 mm from granular layer [Figure 2] and [Figure 3]. Immunohistochemistry for S100 and HMB45 was positive [Figure 4] and [Figure 5]. Fine needle aspiration cytology (FNAC) from right inguinal lymph node showed scattered malignant cells most of which had eccentric rounded nuclei, conspicuous nucleoli and voluminous cytoplasm compatible with metastasis from melanoma but the melanin pigment was absent.

Magnetic resonance imaging (MRI scan) of the involved extremity showed soft tissue mass in the posterolateral aspect of right thigh and right inguinal adenopathy. Abdominal and pelvic ultrasound did not reveal any abnormality. The patient was referred to oncosugery department for surgical intervention where wide local excision and split thickness grafting was done. He followed up in our OPD after three months and showed no evidence of recurrence till date.

  Discussion Top

The clinical diagnosis of malignant melanoma is usually based on cutaneous examination. A history of change in the color, shape or size of a previously existing pigmented lesion or de novo appearance of a pigmented lesion arouses suspicion of melanoma. In absence of usual pigmentation, it is difficult to make a diagnosis of melanoma. AM is a rare variant of melanoma which has little or no melanin pigment.

Melanoma susceptibility gene is CDKN2A located on chromosome 9p21. [3] Cutaneous melanoma very often have a mutation in either NRAS or the BRAF genes, suggesting that either of these oncogenes may lead to development of melanoma due to increase signaling through the mitogen-activated protein (MAP) kinase pathway. [4] There are four clinicopathologic variants of malignant melanoma-superficial spreading, lentigo maligna, nodular and acral lentiginous. [5] AM can have any one of the above morphology but nodular is the most common variety. [5] AM may represent a primary melanoma, a recurrence of a previously pigmented melanoma, or a metastasis from pigmented primary melanoma. A peripheral pigmented rim or border can be seen in some cases which may provide a diagnostic clue. [1] Some authorities have suggested three clinical presentations for AM: an erythematous macule with epidermal changes on sun-exposed skin, a skin coloured dermal plaque without epidermal changes and a papulo-nodular lesion. [6]

Histopathology and immunohistochemistry are essential for diagnosis of AM. Dermatoscopy is upcoming noninvasive diagnostic tool for AM. [7] The prognosis of cutaneous AM is determined by tumor thickness, location, and patient's age and sex - similar to its pigmented counterpart. In some cases, there is evidence of some pigment melanin on histopathology and immunohistochemistry, which includes S100 (positive for melanocytes) and HMB-45 (positive for premelanosomes). Many hypothesis have been proposed to explain the lack of pigment including: lack of tyrosinase, agenesis of melanosomes or abnormal melanogenesis, [8] while others have suggested that amelanotic tumors produce melanin, but in undetectable levels. [9] AM should be regarded as poorly differentiated form of melanotic melanoma with grave prognosis if not treated timely. [10]

  Acknowledgement Top

We would like to thank Dr Nimish Mehta and Tata Memorial Hospital for helping us.

  References Top

1.Gualandri L, Betti R, Crosti C. Clinical features of 36 cases of amelanotic melanomas and considerations about the relationship between histologic subtypes and diagnostic delay. J Eur Acad Dermatol Venereol 2009;23:283-7.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Oguri H, Izumiya C, Maeda N, Fukaya T, Moriki T. A primary amelanotic melanoma of the vagina, diagnosed by immunohistochemical staining with HMB-45, which recurred as a pigmented melanoma. J Clin Pathol 2004;57:986-8.   Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Mackie RM. Disorders of cutaneous melanocytes. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology, 7th ed. Oxford: Blackwell Publishing Ltd; 2004. p. 38.25-26.  Back to cited text no. 3      
4.Cruz F 3 rd , Rubin BP, Wilson D, Town A, Schroeder A, Haley A, et al. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res 2003;63:5761-6.  Back to cited text no. 4      
5.Paek SC, Sober AJ, Hensin T, Martin C, Mihm MC, Johnson TM. Cutaneous melanoma. In: Wolff K, Goldsmith LA, Katz SI, Barbara AG, Paller AS, Lefffel DJ, editors. Fitzpatrick's Dermatology in General Medicine, 7th ed. USA: McGraw Hill; 2008. p. 1137-57.  Back to cited text no. 5      
6.Adler MJ, White CR. Amelanotic malignant melanoma. Semin Cutan Med Surg 1997;16:122-30.  Back to cited text no. 6      
7.Chatterjee M. Amelanotic malignant melanoma with multiple secondaries. Indian J Dermatol Venereol Leprol 2006;72:252.  Back to cited text no. 7    Medknow Journal  
8.Conrad N, Jackson B, Goldberg L. Amelanotic lentigo maligna melanoma: A unique case presentation. Dermatol Surg 1999;25:408-11.   Back to cited text no. 8  [PUBMED]  [FULLTEXT]  
9.Cliff S, Otter M, Holden CA. Amelanotic lentigo maligna melanoma of the face: A case report and review of the literature. Clin Exp Dermatol 1997;22:177-9.  Back to cited text no. 9  [PUBMED]    
10.Bhawan J. Amelanotic melanoma or poorly differentiated melanoma. J Cutan Pathol 1980;7:55-6.  Back to cited text no. 10  [PUBMED]    


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow